Antti Salo from Johanna Myllyharju´s group has as shared first authorship in a publication recently published in Human Molecular Genetics.
Dr. Johannes Kettunen received funding for 5 years from the Novo Nordisk Foundation Excellence Grant for Young Researchers within Endocrinology and Metabolism.
Publications in Nature Communications and The Journal of Clinical Investigation by Pihlajaniemi Group
Dr. Valerio Izzi, a member of the Pihlajaniemi research team, has contributed to an article published in Nature Communications.
Sigrid Jusélius Foundation 2017 funding decision awarded in total 517 500€ to the following research project leaders (in alphabetical order): Ala-Korpela Mika, Hiltunen Kalervo and Kastaniotis Alex
PhD-student Prateek Singh and Prof.
Professors Peppi Karppinen (née Koivunen) and Johanna Myllyharju have contributed to an article recently published in Nature Communications.
Academia Researcher, Biocenter Oulu group leader Doc. Justus Reunanen and his research on intestinal microbiota is presented (in Finnish) on the Academy of Finland web page:
The Computational Medicine Research Team published 4 articles and an editorial in the same issue of International Journal of Epidemiology
The researchers in the Computational Medicine Research Team, led by Prof.
Twenty teams have been chosen to solve the grand challenges of our time in Helsinki Challenge, the science-based idea competition. From University of Ou
An article with a title “A novel actin-binding protein serves as a connector and lipid sensor to coordinate motility and invasion in Apicomplexa.” was recently published in Cell Host &
Biocenter Finland consortium with Professor Johanna Myllyharju, Scientific Director of Biocenter Oulu, Chairperson of the Governing Board of Biocenter Finland and Coordinator of the application, ha
Valtioneuvosto nimitti 22.9.2016 professori Johanna Myllyharjun Suomen tieteelliseksi edustajaksi Euroopan molekyylibiologian laboratorion (EMBL) ja Euroopan molekyylibiologian konferenssin (EMBC)
The Lehtiö group published recently an article in Cell Chemical Biology with contributions from the Pihlajaniemi group.
Seppo Vainio and Jingdong Shan have contributed to an article recently published in Nature Communications.
Paras Biopharmaceuticals Finland Oy, a startup company of University of Oulu, has developed technology for the production of an osteoporosis drug and has secured multimillion-euro investment from a
Järvelin, Herzig and Sebert have participated in a multinational study published recently in Nature Genetics.
Nagy II, Xu Q, Naillat F, Ali N, Miinalainen I, Samoylenko A, Vainio SJ. Impairment of Wnt11 function leads to kidney tubular abnormalities and secondary glomerular cystogenesis. BMC Dev.
Computational Medicine Research Team published an article related to the metabolic effects of alcohol consumption.
The rectors of Biocenter Finland partner Universities have nominated Professor Marja Makarow as new director of Biocenter Finland.
Professor Seppo Vainio´s interview about organogenesis and stem cells can be found on the University of Oulu page.
Dr Mäkinen & Prof Ala-Korpela published a letter in PNAS: Metabolomics of aging requires large-scale longitudinal stud
Drs Kettunen & Würtz awarded 3-y Academy of Finland Research Grants 330k€ each
I4Future is an International, Interdisciplinary & Inter-sectorial doctoral programme starting at the University of Oulu in Finland.